Philippe Klein
5Patents
2h-index
9Co-inventors
40Inventor score
Filing activity: Jul 30, 2004 → May 1, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7713524B2 | Use of ADCC-optimized antibodies for treating low-responder patients | Emerging Cross-Sectional Technologies | 26 | Expired |
| US8501171B2 | Use of ADCC-optimized antibodies for treating weak patients | Emerging Cross-Sectional Technologies | 6 | Active |
| US10059760B2 | Immunoglobulin against the anthrax toxin | Physics | 0 | Active |
| US9109020B2 | Use of ADCC-optimized antibodies for treating weak patients | Emerging Cross-Sectional Technologies | 0 | Active |
| US9879089B2 | Use of ADCC-optimized antibodies for treating low-responder patients | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.